Cardiovascular prevention with lipid-lowering therapy in elderly

By Philippe F.  

Annales de Cardiologie et d'Angeiologie, Vol. 52, Iss. 4, 2003-08 ,pp. : 246-253

Elsevier

Access to resources Recommend Favorite

Target achievement with maximal statin‐based lipid‐lowering therapy in Korean patients with familial hypercholesterolemia: A study supported by the Korean Society of Lipid and Atherosclerosis

By  

Clinical Cardiology, Vol. 40, Iss. 12, 2017-12 ,pp. : 1291-1296

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lipid-lowering Therapy in the Diabetic Foot: Seeing the Whole Iceberg and not Just the Tip

By  

Current Vascular Pharmacology, Vol. 12, Iss. 5, 2014-01 ,pp. : 745-750

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of lipid-lowering treatment on platelet reactivity and platelet-leukocyte aggregation in diabetic patients without and with chronic kidney disease: a randomized trial

By Almquist Tora   Jacobson Stefan H.   Lins Per-Eric   Farndale Richard W.   Hjemdahl Paul  

Nephrology Dialysis Transplantation, Vol. 27, Iss. 9, 2012-09 ,pp. : 3540-3546

Oxford University Press

Access to resources Recommend Favorite

Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia

By  

Current Vascular Pharmacology, Vol. 8, Iss. 6, 2010-11 ,pp. : 820-830

Bentham Science Publishers

Access to resources Recommend Favorite